Status:
UNKNOWN
Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age
Lead Sponsor:
Ministry of Health, Turkey
Collaborating Sponsors:
Hacettepe University
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Conditions:
COVID-19
Eligibility:
All Genders
15+ years
Brief Summary
This study is an observational study (Non-interventional study) to evaluate the safety and efficacy of favipiravir in patients older than 15 years of age, diagnosed with COVID-19 and initiated treatme...
Detailed Description
The clinical picture of 2019-nCoV disease is in a broad spectrum, which includes asymptomatic infection, a mild upper respiratory tract infection, respiratory failure, and even severe viral pneumonia ...
Eligibility Criteria
Inclusion
- Male and female patients, diagnosed with Covid-19 disease who are 15 years of age or older at the time of enrollment
- Patients who have understood all study procedures that will be applied under the study protocol
- Patients with confirmed diagnosis of COVID-19 by PCR and/or other accepted methods and have a treatment decision with favipiravir
- Patients who will accept oropharyngeal sample and venous blood sample collection periodically within the scope of the study protocol
Exclusion
- Patients who are pregnant or females who are breast feeding
- Patients under the age of 15
Key Trial Info
Start Date :
June 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04474457
Start Date
June 11 2020
End Date
June 1 2021
Last Update
February 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University, School of Medicine
Ankara, Turkey (Türkiye)